DexCom, Inc.
DXCM
$89.53
$1.882.15%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.97B | 4.82B | 4.66B | 4.52B | 4.30B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.97B | 4.82B | 4.66B | 4.52B | 4.30B |
| Cost of Revenue | 1.86B | 1.85B | 1.86B | 1.85B | 1.77B |
| Gross Profit | 3.10B | 2.96B | 2.80B | 2.67B | 2.53B |
| SG&A Expenses | 1.36B | 1.33B | 1.29B | 1.30B | 1.27B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.83B | 3.78B | 3.75B | 3.74B | 3.61B |
| Operating Income | 1.14B | 1.03B | 911.80M | 777.70M | 687.20M |
| Income Before Tax | 1.28B | 1.20B | 1.09B | 959.00M | 784.10M |
| Income Tax Expenses | 280.30M | 273.20M | 252.10M | 238.30M | 212.60M |
| Earnings from Continuing Operations | 999.70 | 930.40 | 836.30 | 720.70 | 571.50 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 999.70M | 930.40M | 836.30M | 720.70M | 571.50M |
| EBIT | 1.14B | 1.03B | 911.80M | 777.70M | 687.20M |
| EBITDA | 1.40B | 1.29B | 1.16B | 1.02B | 923.30M |
| EPS Basic | 2.59 | 2.39 | 2.14 | 1.84 | 1.46 |
| Normalized Basic EPS | 2.07 | 1.94 | 1.75 | 1.54 | 1.26 |
| EPS Diluted | 2.53 | 2.34 | 2.09 | 1.80 | 1.43 |
| Normalized Diluted EPS | 2.01 | 1.87 | 1.69 | 1.48 | 1.21 |
| Average Basic Shares Outstanding | 1.55B | 1.56B | 1.56B | 1.56B | 1.57B |
| Average Diluted Shares Outstanding | 1.59B | 1.61B | 1.62B | 1.63B | 1.63B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |